MKS Instruments Inc (MKSI)
Official siteTECHNOLOGY • SCIENTIFIC & TECHNICAL INSTRUMENTS • NASDAQ
Market Cap: $14.58B
Last updated: Nov 17, 2026 at 11:06 AM ET
MKS Instruments Inc (MKSI) Financials: Revenue, Profit and Cash Flow
MKS Instruments reported revenue of $3.93B for the fiscal year ended Dec 31, 2025, up 9.6% from the year before. That year, net income was $295.00M with a net margin of 7.5%, operating cash flow was $645.00M and free cash flow was $497.00M. The quarter ended Sep 30, 2026 had revenue of $1.41B and net income of $236.00M.
Revenue and Margins
The operating margin was 13.4% in the fiscal year ended Dec 2025. Over the 9 years to Dec 2025, revenue grew from $1.30B, a compound annual rate of 13.1%.
| Fiscal year | Revenue | Growth | Gross margin | Operating margin | Net margin |
|---|---|---|---|---|---|
| Dec 2025 | $3.93B | +9.6% | 46.7% | 13.4% | 7.5% |
| Dec 2024 | $3.59B | -1.0% | 47.6% | 13.9% | 5.3% |
| Dec 2023 | $3.62B | +2.1% | 45.3% | -42.9% | -50.8% |
| Dec 2022 | $3.55B | +20.2% | 43.6% | 17.4% | 9.4% |
| Dec 2021 | $2.95B | +26.6% | 46.8% | 23.7% | 18.7% |
| Dec 2020 | $2.33B | +22.6% | 45.0% | 19.5% | 15.0% |
| Dec 2019 | $1.90B | -8.4% | 43.7% | 11.6% | 7.4% |
| Dec 2018 | $2.08B | +8.3% | 47.2% | 23.8% | 18.9% |
| Dec 2017 | $1.92B | +47.9% | 46.5% | 21.2% | 17.7% |
| Dec 2016 | $1.30B | N/A | 100.0% | 12.1% | 8.1% |
Income Statement
In the fiscal year ended Dec 2025, net income rose 55.3% from the year before. In the quarter ended Sep 2026, net income rose 218.9% from the same quarter a year earlier.
Annual
| Line item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $3.93B | $3.59B | $3.62B | $3.55B | $2.95B | $2.33B | $1.90B | $2.08B | $1.92B | $1.30B |
| Cost of revenue | $2.09B | $1.88B | $1.98B | $2.00B | $1.57B | $1.28B | $1.07B | $1.10B | $1.02B | $0 |
| Gross profit | $1.84B | $1.71B | $1.64B | $1.55B | $1.38B | $1.05B | $830.40M | $979.50M | $891.45M | $1.30B |
| Research and development | $299.00M | $271.00M | $288.00M | $241.00M | $200.00M | $173.00M | $164.10M | $135.70M | $132.56M | $110.58M |
| Operating income | $528.00M | $498.00M | -$1.55B | $617.00M | $699.00M | $454.00M | $219.80M | $494.10M | $406.63M | $157.27M |
| Net income | $295.00M | $190.00M | -$1.84B | $333.00M | $551.00M | $350.00M | $140.40M | $392.90M | $339.13M | $104.81M |
| EBITDA | $882.00M | $878.00M | -$1.15B | $930.00M | $796.00M | $553.00M | $341.20M | $576.60M | $568.85M | $246.31M |
Quarterly
| Line item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $1.41B | $1.25B | $1.08B | $1.03B | $988.00M | $973.00M | $936.00M | $935.00M | $896.00M | $887.00M | $868.00M | $893.00M |
| Gross profit | $674.00M | $595.00M | $507.00M | $479.00M | $461.00M | $453.00M | $444.00M | $442.00M | $432.00M | $419.00M | $415.00M | $411.00M |
| Operating income | $326.00M | $251.00M | $149.00M | $144.00M | $138.00M | $135.00M | $111.00M | $137.00M | $128.00M | $127.00M | $106.00M | $23.00M |
| Net income | $236.00M | $175.00M | $84.00M | $107.00M | $74.00M | $62.00M | $52.00M | $90.00M | $62.00M | $23.00M | $15.00M | -$69.00M |
Balance Sheet
As of Dec 2025, total debt of $4.20B exceeded cash and equivalents by $3.53B.
Annual
| Line item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $8.80B | $8.59B | $9.12B | $11.49B | $4.54B | $3.90B | $3.42B | $2.61B | $2.41B | $2.21B |
| Current assets | $2.51B | $2.47B | $2.70B | $2.79B | $2.15B | $1.80B | $1.43B | $1.46B | $1.24B | $998.77M |
| Cash and equivalents | $675.00M | $714.00M | $875.00M | $909.00M | $966.00M | $608.30M | $414.60M | $644.35M | $333.89M | $228.62M |
| Total liabilities | $6.08B | $6.27B | $6.65B | $7.01B | $1.65B | $1.54B | $1.39B | $741.06M | $825.11M | $970.45M |
| Short-term debt | $51.00M | $50.00M | $93.00M | $93.00M | $9.00M | $14.50M | $12.10M | $3.99M | $2.97M | $10.99M |
| Long-term debt | $4.15B | $4.49B | $4.70B | $4.83B | $808.00M | $815.00M | $871.70M | $343.84M | $389.99M | $601.23M |
| Shareholder equity | $2.72B | $2.32B | $2.47B | $4.48B | $2.89B | $2.36B | $2.02B | $1.87B | $1.59B | $1.24B |
Quarterly
| Line item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $9.23B | $8.94B | $8.73B | $8.80B | $8.78B | $8.83B | $8.56B | $8.59B | $9.02B | $8.86B | $8.93B | $9.12B |
| Total liabilities | $5.95B | $5.95B | $5.92B | $6.08B | $6.18B | $6.27B | $6.20B | $6.27B | $6.63B | $6.63B | $6.51B | $6.65B |
| Cash and equivalents | $676.00M | $611.00M | $569.00M | $675.00M | $697.00M | $674.00M | $655.00M | $714.00M | $861.00M | $850.00M | $845.00M | $875.00M |
| Shareholder equity | $3.29B | $2.99B | $2.81B | $2.72B | $2.60B | $2.55B | $2.35B | $2.32B | $2.40B | $2.23B | $2.42B | $2.47B |
Cash Flow
In the fiscal year ended Dec 2025, free cash flow was 77.1% of operating cash flow. Dividends and share repurchases together came to 20.9% of it.
Annual
| Line item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $645.00M | $528.00M | $319.00M | $529.00M | $640.00M | $513.00M | $244.50M | $413.80M | $355.22M | $180.10M |
| Capital expenditures | $148.00M | $118.00M | $87.00M | $164.00M | $87.00M | $85.00M | $63.90M | $62.90M | $31.29M | $19.12M |
| Free cash flow | $497.00M | $410.00M | $232.00M | $365.00M | $553.00M | $428.00M | $180.60M | $350.90M | $323.94M | $160.97M |
| Dividends paid | $59.00M | $59.00M | $59.00M | $52.00M | $47.00M | $44.00M | $43.50M | $42.40M | $38.18M | $36.36M |
| Share repurchases | $45.00M | $0 | $0 | N/A | N/A | N/A | N/A | $75.00M | N/A | $1.54M |
| Investing cash flow | -$145.00M | -$117.00M | -$84.00M | -$4.55B | -$205.00M | -$202.00M | -$947.20M | $72.70M | $22.64M | -$726.99M |
| Financing cash flow | -$562.00M | -$549.00M | -$259.00M | $3.97B | -$65.00M | -$122.00M | $476.20M | -$178.00M | -$279.69M | $560.12M |
Quarterly
| Line item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $292.00M | $243.00M | $53.00M | $142.00M | $197.00M | $165.00M | $141.00M | $176.00M | $163.00M | $122.00M | $67.00M | $181.00M |
| Capital expenditures | $49.00M | $54.00M | $25.00M | $50.00M | $51.00M | $29.00M | $18.00M | $51.00M | $22.00M | $27.00M | $18.00M | $34.00M |
| Free cash flow | $243.00M | $189.00M | $28.00M | $92.00M | $146.00M | $136.00M | $123.00M | $125.00M | $141.00M | $95.00M | $49.00M | $147.00M |
Frequently Asked Questions About MKSI
What is MKS Instruments' annual revenue?
MKS Instruments reported revenue of $3.93B for the fiscal year ended Dec 31, 2025.
How fast is MKS Instruments' revenue growing?
Revenue was up 9.6% for the fiscal year ended Dec 31, 2025 compared with the year before. The compound annual revenue growth rate over 3 years was 3.5%.
Is MKS Instruments profitable?
Yes. MKS Instruments reported net income of $295.00M for the fiscal year ended Dec 31, 2025, with a net margin of 7.5%.
How much free cash flow does MKSI generate?
For the fiscal year ended Dec 31, 2025, operating cash flow of $645.00M minus capital expenditures of $148.00M produced free cash flow of $497.00M.
How much debt does MKS Instruments have?
The balance sheet dated Dec 31, 2025 reported long-term debt of $4.15B, short-term debt of $51.00M and cash and equivalents of $675.00M.
MKSI pages: Overview, Dividends, Earnings, Forecast, Financials, Valuation, Competitors